Patents by Inventor Maria Fernanda Villagra

Maria Fernanda Villagra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150190458
    Abstract: Described are various methods for stabilizing pharmaceutical formulations of a specific Hepatitis C Viral (HCV) inhibitor against the formation of a particular genotoxic degradation product. Such methods include temperature control, moisture control, excipient control, capsule shell control, basification and a reconstitution approach.
    Type: Application
    Filed: March 20, 2015
    Publication date: July 9, 2015
    Inventors: Mathias BRAUN, Carl Alan BUSACCA, Feng-Jing CHEN, Edwin Louis GUMP, Jenness B. MAJESKA, Scott PENNINO, Fenghe QIU, Maria Fernanda VILLAGRA
  • Publication number: 20150038532
    Abstract: A pharmaceutical composition of the following Compound (1), a potent hepatitis C viral (HCV) inhibitor, or a pharmaceutically acceptable salt thereof, for oral administration.
    Type: Application
    Filed: October 17, 2014
    Publication date: February 5, 2015
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Feng-Jing CHEN, Juan Francisco GEL, Maria Fernanda VILLAGRA
  • Publication number: 20140037719
    Abstract: Described are various methods for stabilizing pharmaceutical formulations of a specific Hepatitis C Viral (HCV) inhibitor against the formation of a particular genotoxic degradation product. Such methods include temperature control, moisture control, excipient control, capsule shell control, basification and a reconstitution approach.
    Type: Application
    Filed: January 10, 2013
    Publication date: February 6, 2014
    Applicant: Boehringer Ingelheim International Gmbh
    Inventors: Mathias BRAUN, Carl Alan BUSACCA, Feng-Jing CHEN, Edwin Louis GUMP, Jenness B. MAJESKA, Scott PENNINO, Fenghe QIU, Maria Fernanda VILLAGRA
  • Publication number: 20120101049
    Abstract: A pharmaceutical composition of the following Compound (1), a potent hepatitis C viral (HCV) inhibitor, or a pharmaceutically acceptable salt thereof, for oral administration.
    Type: Application
    Filed: November 18, 2009
    Publication date: April 26, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Feng-Jing Chen, Juan Francisco Gel, Maria Fernanda Villagra
  • Publication number: 20100152244
    Abstract: A self-emulsifying formulation of tipranavir for oral administration.
    Type: Application
    Filed: May 21, 2008
    Publication date: June 17, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Sara Abelaira, Mariela Paula Becher, Juan Francisco Gel, Maria Fernanda Villagra, Marta Noemi Cicconi de Vidal